SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Injective taken over by the community.

Nonja

NONJA CRYPTO is garnering significant attention as the Injective ecosystem prepares for a potential altseason, bolstered by its recent EVM mainnet launch and anticipation of upcoming Injective ETFs. The community is highly bullish, viewing $NONJA as the top memecoin on Injective and a leveraged play on the chain's projected growth, highlighting its strong community, high burned liquidity, and undervalued status for substantial future gains.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending following the FDA approval of YARTEMLEA, the first and only therapy for transplant-associated thrombotic microangiopathy (TA-TMA) in adults and children, marking a significant de-risking event for the company. The community is celebrating this long-awaited milestone, with many long-term holders anticipating substantial upside due to the drug's breakthrough status and lack of competition, along with expectations of a strategic acquisition and continued undervaluation.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injective is drawing significant attention from institutional interest, driven by Pineapple Financial's $100 million fundraise to acquire and stake INJ, alongside a CBOE filing for a staked INJ ETF. The community is actively discussing these developments, with particular excitement around meme coin $NONJA, which many view as a high-leverage play on Injective's continued growth within the finance and derivatives sector. This confluence of institutional backing and ecosystem momentum positions INJ as a prominent discussion point.

Grayscale Ethereum Trust (ETH) operates as open-end investment company. Its investment objective is for the shares to reflect the value of ETH held by the trust. The company was founded on December 13, 2017 and is headquartered in Stamford, CT.

Grayscale Ethereum Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Ethereum Mini Trust

Ethereum is trending due to significant institutional interest, with major asset managers tokenizing funds on its network and increased corporate accumulation highlighting its foundational role in digital finance. The community is buzzing about the upcoming Fusaka network upgrade, expected to boost scalability, and actively debating whether recent price action signifies a market bottom and a potential short squeeze for the asset. This growing institutional trust and technological advancement underscore Ethereum's position as a key infrastructure for the evolving Web3 economy.

Sprott Physical Silver Trust - Units

Sprott Physical Silver Trust ET

Sprott Physical Silver Trust (PSLV) is trending amidst silver's historic surge to new all-time highs, driven by a tightening global supply and escalating industrial demand from sectors like EVs and AI. The community is intensely focused on an anticipated 'silver squeeze,' favoring physical-backed assets like PSLV over traditional paper ETFs due to widespread concerns over market manipulation and the metal's significant undervaluation.

Expand Energy Corp. engages in the production and development of natural gas, oil, and natural gas liquids. Its operations include Haynesville, Northeast Appalachia, and Southwest Appalachia. The company was founded in 2024 and is headquartered in Oklahoma City, OK.

Expand Energy Corp. - Ordinary Shares - New

Expand Energy ($EXE) is gaining significant attention following its inclusion in the S&P 500, a move expected to drive increased institutional buying and liquidity. The community is actively discussing its strategic role as a major natural gas producer, poised to benefit from firming natural gas prices and the growing energy demands of AI data centers, which has resulted in a wave of optimistic analyst upgrades and price targets.

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.

NeOnc Technologies Holdings Inc.

NeOnc Technologies is drawing attention following updated clinical results for its NEO100 brain cancer therapy, which demonstrated promising efficacy and long-term survival. The community is actively discussing a pivotal $50 million strategic partnership with Quazar Investment, poised to fund critical clinical trials and drive expansion into the Middle East. With upcoming data readouts and operational milestones, market participants are keenly watching for execution velocity and further pipeline advancements.

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA.

Cytokinetics Inc

Cytokinetics is gaining significant attention following FDA approval of MYQORZO for obstructive hypertrophic cardiomyopathy, establishing it as a commercial-stage biotech. The community is actively discussing the drug's differentiated label and improved patient experience compared to existing treatments, alongside renewed speculation of potential merger and acquisition interest. This landmark approval positions CYTK for substantial market opportunity and is driving analyst upgrades.

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group Inc.

Altria Group is generating significant conversation as its strategic shift toward reduced-risk products gains momentum, notably with the FDA-approved on! PLUS nicotine pouches. The community is weighing its robust dividend and recent share buyback expansion against the ongoing transition in the tobacco sector and potential future opportunities in the cannabis market.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont (NEM) is at the center of investor discussions amidst a surging gold market, prompting varied community sentiment regarding its performance relative to peers. While some express frustration over its stock fluctuations despite strong cash flow, many see recent dips as a compelling buying opportunity. The broader precious metals rally, fueled by escalating safe-haven demand and increased central bank activity, continues to fuel strong interest in NEM.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ERAS Erasca press release (ERAS): Q3 GAAP EPS of -$0.11 in-line. 
Cash, cash equivalents, and marketable securities were $362.4 million as of September 30, 2025, compared to $440.5 million as of December 31, 2024.  
Erasca expects its cash, cash equivalents, and marketable securities balance to fund operations into the second half of 2028.

StockTwits Web

Erasca Inc

 Erasca press release (ERAS): Q3 GAAP EPS of -$0.11 in-line. 
Cash, cash equivalents, and marketable securities were $362.4 million as of September 30, 2025, compared to $440.5 million as of December 31, 2024.  
Erasca expects its cash, cash equivalents, and marketable securities balance to fund operations into the second half of 2028.